DTL
CYTK icon

Dynamic Technology Lab’s Cytokinetics CYTK Stock Holding History

Dynamic Technology Lab’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,404
Closed -$1.43M – 1032
2024
Q1 		$1.43M Buy
+20,404
New +$1.58M 0.15% 211
2023
Q4 		– Sell
-14,500
Closed -$427K – 1105
2023
Q3 		$427K Sell
14,500
-1,178
-8% -$39.2K 0.04% 542
2023
Q2 		$511K Buy
+15,678
New +$580K 0.06% 496
2023
Q1 		– Sell
-30,390
Closed -$1.39M – 1168
2022
Q4 		$1.39M Buy
30,390
+15,501
+104% +$667K 0.14% 234
2022
Q3 		$721K Buy
14,889
+9,129
+158% +$439K 0.07% 487
2022
Q2 		$226K Buy
+5,760
New +$232K 0.03% 873
2021
Q3 		– Sell
-16,749
Closed -$331K – 1161
2021
Q2 		$331K Buy
+16,749
New +$393K 0.03% 747
2020
Q4 		– Sell
-21,795
Closed -$472K – 1060
2020
Q3 		$472K Buy
+21,795
New +$510K 0.08% 472
2020
Q1 		– Sell
-18,795
Closed -$199K – 1096
2019
Q4 		$199K Buy
+18,795
New +$193K 0.03% 838
2017
Q3 		– Sell
-14,602
Closed -$177K – 1100
2017
Q2 		$177K Buy
+14,602
New +$203K 0.03% 898
2017
Q1 		– Sell
-12,102
Closed -$147K – 1015
2016
Q4 		$147K Buy
+12,102
New +$128K 0.04% 773

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Dynamic Technology Lab's CYTK Position: Q2 2024 in Review

Dynamic Technology Lab sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 20,404 shares — an estimated $1.43M sold.

Dynamic Technology Lab first reported a position in CYTK in Q4 2016 and held it in 11 quarters. The position peaked at $1.43M in Q1 2024. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Dynamic Technology Lab reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 20,404 Cytokinetics shares in Q2 2024, an estimated $1.43M.
  • Dynamic Technology Lab first reported a position in Cytokinetics in Q4 2016 and held it in 11 quarters.
  • Dynamic Technology Lab's Cytokinetics position peaked at $1.43M in Q1 2024.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Dynamic Technology Lab's 13F filing for Q2 2024, filed 15 Aug 2024.